Study of the Relationship Between Sleep Quality and Daytime-Nighttime Variations of Blood Pressure and Plasma Glucose Type I
- Conditions
- Type 1 Diabetes
- Registration Number
- NCT00805974
- Lead Sponsor
- University Hospital, Grenoble
- Brief Summary
The primary objectives are to compare the mean levels of the sleep quality parameters of subjects : with a nocturnal fall of the SBP (Systolic blood pressure), DBP (diastolic blood pressure) and MAP (mean arterial pressure) over of egal to 10% (dipping subjects) and of subjects with a nocturnal fall of SBP, DBP and MAP inferior to 10% (non dipper subjects).
The secondary objectives are :
Establish correlations between:
* The quality of sleep parameters
* The parameters of BP variations between the diurnal and nocturnal periods and the awake periods of sleep defined in reference to polysomnography.
* The glycemia levels on 24h with a glycemic holter. The parameters of the sympathic system activation evaluated in reference to the measure of the baroreflex sensibility during the awake period.
- Detailed Description
It is a prospective monocentric study after a preliminary period of depistage of the sleep abnormalities by oximetry at home. The patient would be hospitalized for two consecutive days (J0, J1). And the following evaluations will be done:
* Nocturnal oxymetric + Epworth questionnaire + clinical questionnaire to detect sleep perturbations at home.
* Blood pressure + heart rate measure
* Ambulatory blood pressure monitoring on 24 hours
* Polysomnographic measurements during the J0-J1 night spend at the hospital.
* Questionnaire of sleep quality and of quality of life.
* Glycemic measurements on 24h (J0-J1).
* Measure of the baroreflex sensibility during the awake period at J1.
* Electrocardiogram
* Biological examinations (blood and urinary).
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 23
- Male and female patients between 18 and 60 years of age
- Who have given their written consent to participate in this study
- Who are affiliated to the French social security system
- Are able to travel to Grenoble University Hospital
- Type I diabetes in reference to the 1997 criteria (American Diabetes Association) without any recent cetoacidosis or severe hypoglycaemia during the previous month and with a HbA1c < 10% during the previous month.
- Normal blood pressure or essential hypertension light or moderate (SBP) at rest in the sitting position >= 140 mmHg and < 180 mmHg and/or PAD >= 90 mmHg et < 110 mmHg), with or without treatment.
- Non stabilised diabetes with at least one episode of acidoketosis decompensation or hypoglycemic coma during the previous month.
- Diabetic nephropathy patent stage 4 with a creatinine > 150 mol / L and / or creatinine clearance <50 ml / min
- Diabetic nephropathy in evolution
- Severe hypertension (SBP at rest in the sitting position >= 180 mmHg and/or DBP >= 110 mmHg)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Polysomnographic measurements during the D0-D1 night spend at the hospital inclusion visit Ambulatory blood pressure monitoring on 24 hours inclusion visit
- Secondary Outcome Measures
Name Time Method Glycemic measurements on 24h (D0-D1). inclusion visit
Trial Locations
- Locations (1)
University Hospital
🇫🇷Grenoble, France